Targeting the prodromal stage of spinocerebellar ataxia type 17 mice: G-CSF in the prevention of motor deficits via upregulating chaperone and autophagy levels

Ya Chin Chang, Chia Wei Lin, Chen Ming Hsu, Guey Jen Lee-Chen, Ming Tsan Su, Long Sun Ro, Chiung Mei Chen, Hei Jen Huang, Hsiu Mei Hsieh-Li

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Spinocerebellar ataxia type 17 (SCA17), an autosomal dominant cerebellar ataxia, is a devastating, incurable disease caused by the polyglutamine (polyQ) expansion of transcription factor TATA binding protein (TBP). The polyQ expansion causes misfolding and aggregation of the mutant TBP, further leading to cytotoxicity and cell death. The well-recognized prodromal phase in many forms of neurodegeneration suggests a prolonged period of partial neuronal dysfunction prior to cell loss that may be amenable to therapeutic intervention. The objective of this study was to assess the effects and molecular mechanisms of granulocyte-colony stimulating factor (G-CSF) therapy during the pre-symptomatic stage in SCA17 mice. Treatment with G-CSF at the pre-symptomatic stage improved the motor coordination of SCA17 mice and reduced the cell loss, insoluble mutant TBP protein, and vacuole formation in the Purkinje neurons of these mice. The neuroprotective effects of G-CSF may be produced by increases in Hsp70, Beclin-1, LC3-II and the p-ERK survival pathway. Upregulation of chaperone and autophagy levels further enhances the clearance of mutant protein aggregation, slowing the progression of pathology in SCA17 mice. Therefore, we showed that the early intervention of G-CSF has a neuroprotective effect, delaying the progression of SCA17 in mutant mice via increases in the levels of chaperone expression and autophagy.

Original languageEnglish
Pages (from-to)132-148
Number of pages17
JournalBrain Research
Volume1639
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Prodromal Symptoms
Autophagy
Granulocyte Colony-Stimulating Factor
TATA-Box Binding Protein
Mutant Proteins
Neuroprotective Agents
Cerebellar Ataxia
MAP Kinase Signaling System
Purkinje Cells
Vacuoles
Cell Death
Transcription Factors
Up-Regulation
Spinocerebellar Ataxia 17
Pathology
Therapeutics
polyglutamine
Proteins

Keywords

  • Autophagy
  • Chaperone
  • G-CSF
  • SCA17
  • Spinocerebellar ataxia

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Targeting the prodromal stage of spinocerebellar ataxia type 17 mice : G-CSF in the prevention of motor deficits via upregulating chaperone and autophagy levels. / Chang, Ya Chin; Lin, Chia Wei; Hsu, Chen Ming; Lee-Chen, Guey Jen; Su, Ming Tsan; Ro, Long Sun; Chen, Chiung Mei; Huang, Hei Jen; Hsieh-Li, Hsiu Mei.

In: Brain Research, Vol. 1639, 01.01.2016, p. 132-148.

Research output: Contribution to journalArticle

@article{5c26d4b3c30e4600ad1e47fa1855d83c,
title = "Targeting the prodromal stage of spinocerebellar ataxia type 17 mice: G-CSF in the prevention of motor deficits via upregulating chaperone and autophagy levels",
abstract = "Spinocerebellar ataxia type 17 (SCA17), an autosomal dominant cerebellar ataxia, is a devastating, incurable disease caused by the polyglutamine (polyQ) expansion of transcription factor TATA binding protein (TBP). The polyQ expansion causes misfolding and aggregation of the mutant TBP, further leading to cytotoxicity and cell death. The well-recognized prodromal phase in many forms of neurodegeneration suggests a prolonged period of partial neuronal dysfunction prior to cell loss that may be amenable to therapeutic intervention. The objective of this study was to assess the effects and molecular mechanisms of granulocyte-colony stimulating factor (G-CSF) therapy during the pre-symptomatic stage in SCA17 mice. Treatment with G-CSF at the pre-symptomatic stage improved the motor coordination of SCA17 mice and reduced the cell loss, insoluble mutant TBP protein, and vacuole formation in the Purkinje neurons of these mice. The neuroprotective effects of G-CSF may be produced by increases in Hsp70, Beclin-1, LC3-II and the p-ERK survival pathway. Upregulation of chaperone and autophagy levels further enhances the clearance of mutant protein aggregation, slowing the progression of pathology in SCA17 mice. Therefore, we showed that the early intervention of G-CSF has a neuroprotective effect, delaying the progression of SCA17 in mutant mice via increases in the levels of chaperone expression and autophagy.",
keywords = "Autophagy, Chaperone, G-CSF, SCA17, Spinocerebellar ataxia",
author = "Chang, {Ya Chin} and Lin, {Chia Wei} and Hsu, {Chen Ming} and Lee-Chen, {Guey Jen} and Su, {Ming Tsan} and Ro, {Long Sun} and Chen, {Chiung Mei} and Huang, {Hei Jen} and Hsieh-Li, {Hsiu Mei}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.brainres.2016.03.004",
language = "English",
volume = "1639",
pages = "132--148",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Targeting the prodromal stage of spinocerebellar ataxia type 17 mice

T2 - G-CSF in the prevention of motor deficits via upregulating chaperone and autophagy levels

AU - Chang, Ya Chin

AU - Lin, Chia Wei

AU - Hsu, Chen Ming

AU - Lee-Chen, Guey Jen

AU - Su, Ming Tsan

AU - Ro, Long Sun

AU - Chen, Chiung Mei

AU - Huang, Hei Jen

AU - Hsieh-Li, Hsiu Mei

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Spinocerebellar ataxia type 17 (SCA17), an autosomal dominant cerebellar ataxia, is a devastating, incurable disease caused by the polyglutamine (polyQ) expansion of transcription factor TATA binding protein (TBP). The polyQ expansion causes misfolding and aggregation of the mutant TBP, further leading to cytotoxicity and cell death. The well-recognized prodromal phase in many forms of neurodegeneration suggests a prolonged period of partial neuronal dysfunction prior to cell loss that may be amenable to therapeutic intervention. The objective of this study was to assess the effects and molecular mechanisms of granulocyte-colony stimulating factor (G-CSF) therapy during the pre-symptomatic stage in SCA17 mice. Treatment with G-CSF at the pre-symptomatic stage improved the motor coordination of SCA17 mice and reduced the cell loss, insoluble mutant TBP protein, and vacuole formation in the Purkinje neurons of these mice. The neuroprotective effects of G-CSF may be produced by increases in Hsp70, Beclin-1, LC3-II and the p-ERK survival pathway. Upregulation of chaperone and autophagy levels further enhances the clearance of mutant protein aggregation, slowing the progression of pathology in SCA17 mice. Therefore, we showed that the early intervention of G-CSF has a neuroprotective effect, delaying the progression of SCA17 in mutant mice via increases in the levels of chaperone expression and autophagy.

AB - Spinocerebellar ataxia type 17 (SCA17), an autosomal dominant cerebellar ataxia, is a devastating, incurable disease caused by the polyglutamine (polyQ) expansion of transcription factor TATA binding protein (TBP). The polyQ expansion causes misfolding and aggregation of the mutant TBP, further leading to cytotoxicity and cell death. The well-recognized prodromal phase in many forms of neurodegeneration suggests a prolonged period of partial neuronal dysfunction prior to cell loss that may be amenable to therapeutic intervention. The objective of this study was to assess the effects and molecular mechanisms of granulocyte-colony stimulating factor (G-CSF) therapy during the pre-symptomatic stage in SCA17 mice. Treatment with G-CSF at the pre-symptomatic stage improved the motor coordination of SCA17 mice and reduced the cell loss, insoluble mutant TBP protein, and vacuole formation in the Purkinje neurons of these mice. The neuroprotective effects of G-CSF may be produced by increases in Hsp70, Beclin-1, LC3-II and the p-ERK survival pathway. Upregulation of chaperone and autophagy levels further enhances the clearance of mutant protein aggregation, slowing the progression of pathology in SCA17 mice. Therefore, we showed that the early intervention of G-CSF has a neuroprotective effect, delaying the progression of SCA17 in mutant mice via increases in the levels of chaperone expression and autophagy.

KW - Autophagy

KW - Chaperone

KW - G-CSF

KW - SCA17

KW - Spinocerebellar ataxia

UR - http://www.scopus.com/inward/record.url?scp=84979573644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979573644&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2016.03.004

DO - 10.1016/j.brainres.2016.03.004

M3 - Article

C2 - 26972528

AN - SCOPUS:84979573644

VL - 1639

SP - 132

EP - 148

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -